MEDICATION REVIEW OF ADMITTED WARD PATIENT
1. PATIENT DETAILS:
HOSPITAL NO: 75050172 BED NO: GW41
PATIENT NAME KAPIL KUMARI THAKURI
AGE/SEX: 76Y/F
WEIGHT:
HEIGHT:
WARD: GENERAL WARD
ADDRESS KATHMANDU/NUWAKOT
DATE OF ADMISSION 2076/03/19
DATE OF DISCHARGE 2076/03/23
TOTAL STAY 4
DISCHARGE STATUS IMPROVED
VITAL SIGNS:
DATE 2076/03/19 2076/03/20 2076/03/21 2076/03/22 2076/03/23
BP (MMHG) 110/70 120/80 90/60 100/70 110/70
TEMPERATURE (℉) 97.2 98 97 97 98
PULSE RATE (B/Min) 86 84 94 92 86
SPO2 (%) 2 lit/min 94 98 96 98 98
RESPI RATE (B/min) 26 24 27 24 24
2. CHIEF COMPLAINT:
Fever for 20 days associated with chill and rigor. Patient also complained of body ache, decresed
appetite along with nausea and cough. SOB +, chest pain +, K/C/O COPD,
Normal bowel and bladder habit
3. ON EXAMINATION (O/E):
GC: conscious
PILCYCLOD: NIL
VITALS: BP: 110/70 mmHg PR: 86 bpm RR: 22/min T: 97.2 F SPO2: 94% without O2
SYS EXAMINATION:
CHEST:B/Cl decreased air entry
CVS: S1S2M0
PA: soft, non tender, BS+
1|Page
4. PRE-MEDICATION HISTORY:
Airtech FB 200 mcg rotacap BD
Tiova 18 mcg OD
Doxofylline 400 mg BD
5. PROVISIONAL DIAGNOSIS:
AE of COPD
UTI
6. MEDICATION AFTER PROVISIONAL DIAGNOSIS:
IV fluid
Inj. Montaz 1.125 gm BD
Inj. Aciloc 50 mg TDS
Tab Paracetamol 500 mg QID
7. INVESTIGATION:
LABORATORY FINDINGS:
Date Test Result
2076/03/17 Urine R/E Color light yellow, reaction-acidic,
sugar-nil, pus cell-6 to 8, RBC-0 to 2,
crystal not seen, bacteria not seen,
mucus thread seen, paracyte not seen,
epithelial cell- 4 to 6, albumin nil
Urine culture 24 hrs incubation No growth of microorganism isolated
CBC TLC-5900, neutrophil-73, lymphocyte-
17, eosinophil-0, hemoglobin-12.5
LFT NAD
RFT NAD
Blood sugar random 239
Blood culture No growth of microorganism isolated
2076/03/18 Lipid profile Total cholesterol-201, TG-215, HDL-
cholesterol-42, VLDL-43
Blood sugar fasting, PP Fasting-178, PP-213
2076/03/20 Urine R/E NAD
CASE RELATED OTHER FINDING (USG, X-RAY, CT-SCAN, MRI ETC.) :
Not done
2|Page
8. DIAGNOSIS:
Urinary tract infection
Hypertension
Type II diabetes mellitus
9. MEDICATION AFTER DIAGNOSIS:
SN DRUGS ROA DOSE FREQ. DAYS OF TREATMENT
TRADE NAME GENERIC NAME 3/17 3/18 3/19 3/20 3/21 3/22
1 Montaz IV 1.125g BD √ √
2 Aciloc IV 50 MG TDS √ √ √ √ √
3 Pcm PO 500 MG QID √ √ √
4 Doxyfic IV BD √ √ √
5 Perinorm IV BD √ √ √
6 Tazolin IV BD √ √ √
7 Mylod-LH PO OD √ √ √ √ √ √
8 Siptin-M PO BD √ √ √ √ √ √
9
10
10. RATIONALITY OF PRESCRIPTION/ POSSIBLE DRUG
INTERACTION/MAJOR POSSIBLE ADR
3|Page
11. THERAPEUTIC INTERVENTION BY PHARMACIST:
12. DRUG ADVICE ON DISCHARGE:
S.NO. PRESCRIBED GENERIC NAME DOSE ROA DURATION
MEDICINE
1 Montaz IV 1.125g BD
2 Aciloc IV 50 MG TDS
3 Pcm PO 500 MG QID
4 Doxyfic IV BD
5 Perinorm IV BD
6 Tazolin IV BD
7 Mylod-LH PO OD
8 Siptin-M PO BD
9
10
13. RATIONALITY OF PRESCRIBING MEDICINE/THERAPEUTIC
INTERVENTION PLAN BY PHARMACIST AFTER DISCHARGE:
4|Page
14. DETAILS OF PATIENT COUNSELING:
5|Page